[go: up one dir, main page]

ES2060015T3 - Derivados arilicos anti-inflamatorios. - Google Patents

Derivados arilicos anti-inflamatorios.

Info

Publication number
ES2060015T3
ES2060015T3 ES90301090T ES90301090T ES2060015T3 ES 2060015 T3 ES2060015 T3 ES 2060015T3 ES 90301090 T ES90301090 T ES 90301090T ES 90301090 T ES90301090 T ES 90301090T ES 2060015 T3 ES2060015 T3 ES 2060015T3
Authority
ES
Spain
Prior art keywords
derivatives
arilic
inflammatory
compounds
halophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90301090T
Other languages
English (en)
Inventor
William Paul Jackson
John Anthony Salmon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898902472A external-priority patent/GB8902472D0/en
Priority claimed from GB898919314A external-priority patent/GB8919314D0/en
Priority claimed from GB898924867A external-priority patent/GB8924867D0/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of ES2060015T3 publication Critical patent/ES2060015T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/05—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)

Abstract

EL PRESENTE INVENTO SE OCUPA DE COMPUESTOS DE FORMULA (I) DONDE AR ES UN 4-HALOFENIL; AR ES 1.3- O 1,4-FENILENO; Y ES (E)-CH=CH-; Y R1 Y R (AL CUADRADO) SON ELEGIDOS INDEPENDIENTEMENTE ENTRE HIDROGENO Y ALQUIL C1-4; Y DE LAS SALES BASICAS Y LOS DERIVADOS FISIOLOGICAMENTE FUNCIONALES DE LO MISMO, LOS PROCESOS PARA SU PREPARACION, LAS FORMULACIONES FARMACEUTICAS QUE LAS CONTIENE Y OPCIONALMENTE UNO O MAS INGREDIENTES FARMACOLOGICAMENTE ACTIVOS, DISTINTOS Y EL USO DE ESTOS COMPUESTOS COMO MEDICAMENTOS.
ES90301090T 1989-02-03 1990-02-02 Derivados arilicos anti-inflamatorios. Expired - Lifetime ES2060015T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898902472A GB8902472D0 (en) 1989-02-03 1989-02-03 Anti-inflammatory aryl derivatives
GB898919314A GB8919314D0 (en) 1989-08-25 1989-08-25 Anti-inflammatory aryl derivatives
GB898924867A GB8924867D0 (en) 1989-11-03 1989-11-03 Anti-inflammatory aryl derivatives

Publications (1)

Publication Number Publication Date
ES2060015T3 true ES2060015T3 (es) 1994-11-16

Family

ID=27264299

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90301090T Expired - Lifetime ES2060015T3 (es) 1989-02-03 1990-02-02 Derivados arilicos anti-inflamatorios.

Country Status (16)

Country Link
EP (1) EP0384594B1 (es)
JP (1) JPH02270855A (es)
KR (1) KR900012892A (es)
AT (1) ATE96427T1 (es)
AU (1) AU624896B2 (es)
CA (1) CA2009201A1 (es)
DE (1) DE69004119T2 (es)
DK (1) DK0384594T3 (es)
ES (1) ES2060015T3 (es)
FI (1) FI900536A7 (es)
HU (1) HU208523B (es)
IL (1) IL93259A0 (es)
MC (1) MC2091A1 (es)
NO (1) NO171906C (es)
NZ (1) NZ232350A (es)
PT (1) PT93049A (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120752A (en) * 1989-12-28 1992-06-09 Abbott Laboratories Cyclopropyl derivative lipoxygenase inhibitors
US5476873A (en) * 1990-07-25 1995-12-19 Abbott Laboratories Acetylene derivatives having lipoxygenase inhibitory activity
JPH06256285A (ja) * 1990-12-11 1994-09-13 Pfizer Pharmaceut Co Ltd ヒドロキサム酸誘導体およびその用途
US5130485A (en) * 1991-04-23 1992-07-14 Eli Lilly And Company N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents
US5283361A (en) * 1991-04-23 1994-02-01 Eli Lilly And Company N-hydroxy-N-[3-[2-(halophenylthio)phenyl]prop-2-enyl]ureas as lipoxygenase inhibitors
US5140047A (en) * 1991-05-03 1992-08-18 Smithkline Beecham Corporation Lipoxygenase inhibitors
DE4204686A1 (de) * 1992-02-17 1993-08-19 Gruenenthal Gmbh Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln
US5326787A (en) * 1992-05-12 1994-07-05 Abbott Laboratories Cycloalkyl N-hydroxy derivatives having lipoxygenase inhibitory activity
GB9308652D0 (en) * 1993-04-27 1993-06-09 Wellcome Found Anti-inflammatory compounds
TW448144B (en) * 1993-08-19 2001-08-01 Pfizer Phenoxyphenyl cyclopentenyl hydroxyureas
US5459154A (en) * 1993-11-08 1995-10-17 American Home Products Corporation N-hydroxyureas as 5-lipoxygenase inhibitors and inhibitors of oxidative modification of low density lipoprotein
US5428048A (en) * 1993-11-08 1995-06-27 American Home Products Corporation Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents
US5468760A (en) * 1993-11-08 1995-11-21 American Home Products Corporation Aralkyl-N-hydroxyureas as inhibitors of 5-lipoxygenase and oxidation of low density lipoprotein
EP0891772A3 (en) * 1997-06-18 1999-05-19 Santen Pharmaceutical Co., Ltd. Therapeutic agent for rheumatic disease comprising nonsteroidal anti-inflamatory drug and phenylpropionic acid derivative
CA2465261A1 (en) 2001-10-24 2003-05-01 The Regents Of The University Of California Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
WO2013007371A2 (en) * 2011-07-13 2013-01-17 Eth Zurich Kinetic resolution of chiral amines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT82200B (pt) * 1985-03-16 1990-02-08 Wellcome Found Processo para a preparacao de novos derivados do acido hidroxamico e de composicoes farmaceuticas que os contem
US4728670A (en) * 1986-06-04 1988-03-01 E. R. Squibb & Sons, Inc. Biphenyl hydroxamic acids
US4897422A (en) * 1987-02-10 1990-01-30 Abbott Laboratories Lipoxygenase inhibiting compounds
CA1336099C (en) * 1987-04-24 1995-06-27 James B. Summers, Jr. Urea based lipoxygenase compounds
PL154186B1 (en) * 1987-07-15 1991-07-31 Wellcome Found Method for manufacturing arylic derivatives of the hydroxamic acid

Also Published As

Publication number Publication date
JPH02270855A (ja) 1990-11-05
HUT53071A (en) 1990-09-28
NZ232350A (en) 1992-04-28
NO171906C (no) 1993-05-19
ATE96427T1 (de) 1993-11-15
DE69004119T2 (de) 1994-03-24
DK0384594T3 (da) 1993-12-06
KR900012892A (ko) 1990-09-03
FI900536A0 (fi) 1990-02-02
AU624896B2 (en) 1992-06-25
HU208523B (en) 1993-11-29
HU900656D0 (en) 1990-04-28
NO900504L (no) 1990-08-06
DE69004119D1 (de) 1993-12-02
FI900536A7 (fi) 1990-08-04
PT93049A (pt) 1990-08-31
CA2009201A1 (en) 1990-08-03
EP0384594B1 (en) 1993-10-27
AU4908890A (en) 1990-08-09
EP0384594A1 (en) 1990-08-29
NO900504D0 (no) 1990-02-02
MC2091A1 (fr) 1991-02-15
NO171906B (no) 1993-02-08
IL93259A0 (en) 1990-11-29

Similar Documents

Publication Publication Date Title
ES2060015T3 (es) Derivados arilicos anti-inflamatorios.
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
ES2140391T3 (es) Derivados de dialcoxi-piridinil-bencimidazol, procedimiento para su preparacion y su uso farmaceutico.
ES2174629T3 (es) 14,15-ciclopropano-esteroides de la serie de los 19-nor-androstanos, procedimiento para su preparacion y formulaciones farmaceuticas que contienen estos compuestos.
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ES2084944T3 (es) Amidas terapeuticas.
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
MX9207382A (es) Nuevos compuestos que tienen actividad terapeutica intermediarios para su preparacion, proceso para obtencion de tales compuestos y formulacion farmaceutica que los contiene.
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
ES2038643T3 (es) Procedimiento para la obtencion de una composicion farmaceutica topica.
BR9810729A (pt) Composição farmacêutica para compostos lipofìlicos ácidos disposta como uma formulação auto-emulsionante
ES2062239T3 (es) Diamidas de acidos pirimidin-4,6-dicarboxilicos, procedimiento para su preparacion, utilizacion de las mismas, asi como medicamentos a base de estos compuestos.
MX9301197A (es) Derivados de indol.
ES2043891T3 (es) Procedimiento para preparar nuevos agentes antiarritmicos ii.
ES2090083T3 (es) Derivados de cefalosporina, procedimiento para su preparacion y composicion antimicrobiana que contiene estos derivados.
EP0321968A3 (en) Compounds active on the cardiovascular system
AR015685A1 (es) Compuesto de heteroarilcarboxamida o una sal fisiologicamente aceptable del mismo y su uso para la preparacion de una composicion farmaceutica
ES2039292T3 (es) Derivados de piranobenzoxadiazol, preparacion de los mismos, utilizacion y compuestos que los comprenden.
MX9203577A (es) Nuevos derivados de sinergistinas y composiciones farmaceuticas que los contienen.
NO950177L (no) Farmakologisk aktive erivater
ES2059471T3 (es) Un procedimiento para preparar un derivado de rodamina.
ES2132283T3 (es) Derivados n-heteroaril sustituidos de propanamida utiles en el tratamiento de enfermedades cardiovasculares.
ES2087178T3 (es) Disulfato de ws7622a, procedimiento para su preparacion y su uso.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 384594

Country of ref document: ES